Slow-paced breathing to boost heart rate variability in healthy young adults

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study enrolls healthy adults aged 18 to 25 to practice a structured slow-paced breathing protocol for six weeks. The researchers will measure changes in heart rate variability, which reflects autonomic nervous system balance, and perceived stress, as well as dysfunctional breathing symptoms. The trial uses a low-cost, non-invasive breathing exercise approach to see if it can be integrated into routine clinical practice. Primary outcomes focus on autonomic function and stress, with secondary aims examining breathing pattern improvements. No drug or invasive procedures are involved.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Healthy young adults aged 18 to 25 years.
* Non-smokers.
* Free from any chronic diseases.
* Willingness to complete the 6-week slow-paced breathing intervention protocol.
* Capable of understanding the study requirements and providing written informed consent.

Exclusion Criteria:

* Known cardiovascular, respiratory, or severe neurological disorders.
* History of any chronic disease.
* Active smoking or tobacco use.
* Current use of medications affecting heart rate or the autonomic nervous system.
* Prior regular practice of formal slow-breathing exercises, biofeedback, or yoga breathing techniques.
* Inability to follow the intervention protocol.

Where it's running

• Bahcesehir University, Faculty of Health Sciences, Physical Therapy and Rehabilitation laboratory
  Istanbul, Turkey (Türkiye) Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• How age affects germinal center responses after flu and rabies vaccines

  Researchers will test how the immune system responds to flu and rabies vaccines in younger adults (18–40) and older adults (65+).

  Recruiting Phase 4 Washington University School of Medicine · St Louis, Missouri · NCT07914673

• Magnetic field maps with NV sensors for non-invasive heart measurements

  This study tests whether diamond-based NV magnetometers can non-invasively detect and map the heart's magnetic field in healthy adults.

  Recruiting Robert Bosch GmbH · Renningen · NCT07908173

• Methylation analyses using home-based self-sampling in women with and without gynecological disease

  This study tests whether self-collected urine and vaginal samples can reveal DNA methylation markers that distinguish people with gynecological (pre-)cancers from cancer-free controls.

  Recruiting Universiteit Antwerpen · Edegem, Antwerp · NCT07902388

• Omega-3 status in healthy adults: comparing different fish-oil and algae-oil products

  This study tests whether various fish-oil and algae-oil products can raise the Omega-3 Index in healthy adults who don’t eat much fatty fish.

  Recruiting Nordic Naturals · London, Ontario · NCT07900425

• A safe, carefully dosed test of TBD11 in healthy adults

  This phase 1 study tests TBD11 in healthy adults to see if it is safe and tolerable and to understand how it behaves in the body, including how it interacts with other medicines.

  Recruiting Phase 1 Gates Medical Research Institute · Bloemfontein · NCT07883226

• Fosmanogepix in healthy adults: how it may interact with other drugs and heart rhythm

  This study tests whether fosmanogepix (and its active form manogepix) changes how other medicines work in healthy adults.

  Recruiting Phase 1 Basilea Pharmaceutica · Groningen, Netherlands · NCT07881224

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.